Want to see DE:RHK full AI Analyst Report?

RHON-KLINIKUM AG (RHK) Price & Analysis

0 Followers

RHK Stock Chart & Stats

€12.90

€0.30(1.99%)

At close: Jan 09 4:00 PM EST

€12.90

€0.30(1.99%)

Day’s Range― - ―

52-Week Range€11.30 - €14.30

Previous CloseN/A

Volume1.17K

Average Volume (3M)955.00

Market Cap

€856.81M

Enterprise Value€802.15M

Total Cash (Recent Filing)€578.26M

Total Debt (Recent Filing)€112.47M

Price to Earnings (P/E)21.3

Beta-0.08

Next Earnings

Aug 06, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.56%

Share Statistics

EPS (TTM)0.60

Shares Outstanding66,962,470

10 Day Avg. Volume528

30 Day Avg. Volume955

Financial Highlights & Ratios

PEG Ratio-1.22

Price to Book (P/B)0.64

Price to Sales (P/S)0.44

P/FCF Ratio-24.57

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.64

Revenue Forecast (FY)€1.79B

Bulls Say, Bears Say

Bulls Say

Conservative Balance SheetLow leverage, falling absolute debt (€122m vs ~€150m prior) and rising equity (~€1.32bn in 2025) provide durable financial flexibility. This reduces refinancing and solvency risk, enabling sustained capex, working capital support or selective M&A without stressing liquidity during reimbursement cycles.

Proven Cash-generation HistoryPrior multi-year operating cash generation demonstrates the core hospital operations can convert earnings into cash, supporting recurring reinvestment and debt service. If recent 2025 weakness proves episodic, historical cashability is a structural strength for funding capex and smoothing cyclical revenue swings.

Integrated Hospital Services And ScaleA diversified service mix (inpatient, outpatient, diagnostics, therapy) and multi-specialty hospital platform create recurring, reimbursement-backed revenue streams. Scale and service breadth support patient referrals, utilization stability and cross-selling of ancillary services, underpinning long-term revenue resilience.

Bears Say

Sharp 2025 Operating Profit DeclineA dramatic EBIT collapse despite revenue growth signals structural margin pressure from rising costs, unfavorable case mix, or one-off charges. If persistent, reduced operating profitability will erode the firm's ability to self-fund investments and increase sensitivity to reimbursement or staffing cost shocks over months to years.

Negative Free Cash Flow In 2025A swing to negative FCF and lower OCF reduces financial flexibility and raises the prospect of needing external funding or delaying investments if the trend persists. Structural negative cash conversion risks constrain strategic options and increase vulnerability to higher interest or tighter liquidity conditions.

Thin Margins And Low ReturnsPersistently low margins and modest ROE limit retained earnings for reinvestment and provide little buffer against reimbursement cuts or cost inflation. Structural low profitability weakens long-term capital formation and increases reliance on operational improvements or external capital to raise returns.

RHK FAQ

What was RHON-KLINIKUM AG’s price range in the past 12 months?

RHON-KLINIKUM AG lowest stock price was €11.30 and its highest was €14.30 in the past 12 months.

What is RHON-KLINIKUM AG’s market cap?

RHON-KLINIKUM AG’s market cap is €856.81M.

When is RHON-KLINIKUM AG’s upcoming earnings report date?

RHON-KLINIKUM AG’s upcoming earnings report date is Aug 06, 2026 which is in 14 days.

How were RHON-KLINIKUM AG’s earnings last quarter?

RHON-KLINIKUM AG released its earnings results on May 07, 2026. The company reported €0.19 earnings per share for the quarter, beating the consensus estimate of N/A by €0.19.

Is RHON-KLINIKUM AG overvalued?

According to Wall Street analysts RHON-KLINIKUM AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does RHON-KLINIKUM AG pay dividends?

RHON-KLINIKUM AG pays a Annually dividend of €0.2 which represents an annual dividend yield of 1.56%. See more information on RHON-KLINIKUM AG dividends here

What is RHON-KLINIKUM AG’s EPS estimate?

RHON-KLINIKUM AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does RHON-KLINIKUM AG have?

RHON-KLINIKUM AG has 66,962,470 shares outstanding.

What happened to RHON-KLINIKUM AG’s price movement after its last earnings report?

RHON-KLINIKUM AG reported an EPS of €0.19 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of RHON-KLINIKUM AG?

Currently, no hedge funds are holding shares in DE:RHK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

RHON-KLINIKUM AG Stock Smart Score

Neutral

Technicals

Fundamentals

Return on Equity

1.56%

Trailing 12-Months

Asset Growth

-1.58%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

RHON-KLINIKUM AG

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, delivers extensive healthcare services across Germany, encompassing inpatient, day-patient, and outpatient treatment models. The company's hospitals provide a broad spectrum of medical and surgical care, including cardiovascular rehabilitation, specialized hand and trauma surgery, neurological and psychosomatic treatments, addiction therapy, ophthalmology, and dentistry. They also address conditions affecting the thoracic region, lungs, and vascular system, offer oncology services, and manage neurological conditions, spinal column and joint issues, as well as heart diseases. The organization operates eight hospitals, providing a total of 5,420 beds or patient slots across five distinct medical locations. RHÖN-KLINIKUM is headquartered in Bad Neustadt an der Saale, Germany.